Showing 41 - 60 results of 227,760 for search '(( 10 ((((we decrease) OR (a decrease))) OR (nn decrease)) ) OR ( a d decrease ))', query time: 1.72s Refine Results
  1. 41
  2. 42

    Decrease in Vitamin D Status in the Greenlandic Adult Population from 1987–2010 by Nina O. Nielsen (490187)

    Published 2014
    “…</p><p>Conclusion</p><p>We identified a remarkable decrease in vitamin D status from 1987 to 2005–2010 and a presently low vitamin D status among Inuit in Greenland. …”
  3. 43

    TMEM16A knockdown decreased activation of the MEK-ERK1/2 pathway and expression of cyclin D1. by Yujie Sui (549090)

    Published 2014
    “…<p>Western blot results show inhibition of TMEM16A led to a decrease in phospho-MEK, phospho-ERK1/2 and cyclin D1. …”
  4. 44
  5. 45

    Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

    Published 2013
    “…<div><p>Background and Aim</p><p>Liver cirrhosis is associated with decreased hepatic cytochrome P4503A (CYP3A) activity but the pathogenesis of this phenomenon is not well elucidated. …”
  6. 46
  7. 47
  8. 48
  9. 49

    Chronic Zinc Exposure Decreases the Surface Expression of NR2A-Containing NMDA Receptors in Cultured Hippocampal Neurons by Jia Zhu (135506)

    Published 2012
    “…Whole-cell and synaptic NR2A-mediated currents also decreased. By contrast, zinc did not affect NR2B, suggesting that chronic zinc exposure specifically influences NR2A-containg NMDARs. …”
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54

    CPGF NPs decrease the growth kinetics of breast cancer cells. by Kirtee D. Wani (636463)

    Published 2014
    “…<p>(<b>A</b>) The NPs decreased the number of cells in MDAMB231 and MCF7, indicated by cell growth assay. …”
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60

    <i>Trans ε</i> viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model by Martial Caillaud (6383672)

    Published 2019
    “…Here, effects of this stilbenoid were evaluated in transgenic APPswePS1dE9 mice. We report that <i>trans ε</i>-viniferin could go through the blood brain barrier, reduces size and density of amyloid deposits and decreases reactivity of astrocytes and microglia, after a weekly intraperitoneal injection at 10 mg/kg from 3 to 6 months of age.…”